Literature DB >> 25637199

Invasive aspergillosis in neutropenic patients during hospital renovation: effectiveness of mechanical preventive measures in a prospective cohort of 438 patients.

Michael Loschi1, Caroline Thill, Christian Gray, Marion David, Marie-France Bagatha, Ali Chamseddine, Nathalie Contentin, Fabrice Jardin, Helene Lanic, Emilie Lemasle, Pascal Lenain, Aspasia Stamatoullas, Hervé Tilly, Stephane Lepretre.   

Abstract

BACKGROUND: Aspergillus species are the main cause of invasive fungal disease for patients with severe and prolonged neutropenia. Building or renovation works have been shown as one of the major causes of outbreaks of aspergillosis.
OBJECTIVES: This study aimed to assess the effectiveness of introduction and adaptation by air sampling of mechanical preventive measures on the incidence of invasive pulmonary aspergillosis in neutropenic patients during hospital renovation. PATIENTS: All of the patients admitted for prolonged and severe neutropenia during a renovation period from 2003 to 2008 were prospectively enrolled. Invasive pulmonary aspergillosis (IPA) cases were classified as possible, probable, and proven, according to the 2008 European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group criteria. The effectiveness of preventive measures was determined by air sampling.
RESULTS: We recorded 705 hospitalizations for neutropenia concerning 438 patients. The majority of hospitalized neutropenic patients was treated for acute leukemia (38.3 %), followed by patients suffering from non-Hodgkin and Hodgkin lymphomas (33 %). The total cumulative incidence of probable and proven IPA was 4.1 %. Risk factors for developing IPA were underlying disease, treatment course at the time of hospitalization, and the mean duration of hospitalization and of neutropenia.
CONCLUSIONS: In this prospective study, the incidence of invasive pulmonary aspergillosis did not increase in neutropenic patients during a renovation period because of efficient mechanical preventive measures systematically adjusted using the results of air sampling.

Entities:  

Mesh:

Year:  2015        PMID: 25637199     DOI: 10.1007/s11046-015-9865-6

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  20 in total

1.  Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation.

Authors: 
Journal:  Cytotherapy       Date:  2001       Impact factor: 5.414

2.  Trends in the prevalence of invasive fungal infections from an analysis of annual records of autopsy cases of Toho University.

Authors:  Kayoko Shimodaira; Yoichiro Okubo; Haruo Nakayama; Megumi Wakayama; Minoru Shinozaki; Takao Ishiwatari; Daisuke Sasai; Tetsuo Nemoto; Kei Takahashi; Toshiharu Ishii; Tsutomu Saji; Kazutoshi Shibuya
Journal:  Mycoses       Date:  2012-02-10       Impact factor: 4.377

3.  Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis.

Authors:  Géraldine Salmeron; Raphaël Porcher; Anne Bergeron; Marie Robin; Régis Peffault de Latour; Christèle Ferry; Vanderson Rocha; Anna Petropoulou; Aliénor Xhaard; Claire Lacroix; Annie Sulahian; Gérard Socié; Patricia Ribaud
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

4.  Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.

Authors:  Arlo Upton; Katharine A Kirby; Paul Carpenter; Michael Boeckh; Kieren A Marr
Journal:  Clin Infect Dis       Date:  2007-01-09       Impact factor: 9.079

5.  Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007).

Authors:  O Lortholary; J-P Gangneux; K Sitbon; B Lebeau; F de Monbrison; Y Le Strat; B Coignard; F Dromer; S Bretagne
Journal:  Clin Microbiol Infect       Date:  2011-06-10       Impact factor: 8.067

6.  Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009.

Authors:  Marie-Christine Nicolle; Thomas Bénet; Anne Thiebaut; Anne-Lise Bienvenu; Nicolas Voirin; Antoine Duclos; Mohamad Sobh; Giovanna Cannas; Xavier Thomas; Frank-Emmanuel Nicolini; Frédérique De Monbrison; Marie-Antoinette Piens; Stéphane Picot; Mauricette Michallet; Philippe Vanhems
Journal:  Haematologica       Date:  2011-07-26       Impact factor: 9.941

7.  Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure.

Authors:  Thomas Bénet; Marie-Christine Nicolle; Anne Thiebaut; Marie-Antoinette Piens; Franck-Emmanuel Nicolini; Xavier Thomas; Stéphane Picot; Mauricette Michallet; Philippe Vanhems
Journal:  Clin Infect Dis       Date:  2007-08-08       Impact factor: 9.079

8.  Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy.

Authors:  J J Weems; B J Davis; O C Tablan; L Kaufman; W J Martone
Journal:  Infect Control       Date:  1987-02

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 10.  Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review.

Authors:  Petros Pechlivanoglou; Hoa H Le; Simon Daenen; John A Snowden; Maarten J Postma
Journal:  J Antimicrob Chemother       Date:  2013-08-23       Impact factor: 5.790

View more
  3 in total

Review 1.  Innate host defenses against Cryptococcus neoformans.

Authors:  Camaron Hole; Floyd L Wormley
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

Review 2.  Coinfection of Pulmonary Hydatid Cyst and Aspergilloma: Case Report and Systematic Review.

Authors:  Masoud Aliyali; Hamid Badali; Tahereh Shokohi; Maryam Moazeni; Anahita Nosrati; Gholamali Godazandeh; Somayeh Dolatabadi; Mojtaba Nabili
Journal:  Mycopathologia       Date:  2015-12-14       Impact factor: 2.574

3.  Microsatellite Typing of Aspergillus flavus Strains in a Tunisian Onco-hematology Unit.

Authors:  Soukeina Gheith; Fatma Saghrouni; Anne-Cécile Normand; Wadiaa Bannour; Abderrahim Khelif; Renaud Piarroux; Moncef Ben Said; Mansour Njah; Stéphane Ranque
Journal:  Mycopathologia       Date:  2015-11-18       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.